🎁
DIWALI SPECIAL

20% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

MEDANTA vs SHALBY: Stock Comparison

GLOBAL HEALTH vs SHALBYUpdated 30 Oct 26, 9:36 AM ISTNSE & company filings

GLOBAL HEALTH is the larger company by market capitalisation. GLOBAL HEALTH shows a higher ROE, a higher dividend yield and faster revenue growth, while SHALBY shows a lower P/E and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

MEDANTA leads 8; SHALBY leads 3 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

MEDANTASHALBY

Valuation lens

What price are you paying?

Market CapContext only
₹34,818 Cr
₹1,325 Cr
P/E RatioSHALBY has the lower reading
62.54x
33.71x ✓
P/B RatioSHALBY has the lower reading
8.78x
1.32x ✓
EPSMEDANTA has the higher reading
₹5.9 ✓
₹1
Book ValueContext only
₹148.18
₹93.11
Dividend YieldMEDANTA has the higher reading
0.04% ✓
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
MEDANTA is the larger company
₹34,818 Cr vs ₹1,325 Cr
P/E Ratio
SHALBY has a lower P/E
33.71x vs 62.54x
P/B Ratio
SHALBY has a lower P/B
1.32x vs 8.78x
EPS
MEDANTA has higher earnings per share
₹5.9 vs ₹1
Dividend Yield
MEDANTA has a higher dividend yield
0.04% vs 0%
Revenue Growth (TTM YoY)
MEDANTA has faster revenue growth
24.5% vs 8.5%
EPS Growth (TTM YoY)
MEDANTA has faster EPS growth
42% vs 0%
ROE
MEDANTA has a higher ROE
13.91% vs 9.05%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricMEDANTASHALBY
SectorHealthcareHealthcare
IndustryHospitalHospital

Price

MetricMEDANTASHALBY
Live Price₹1,300.6₹120.41
Day Change0.07%-1.27%
Volume4,7812,835
52-Week High₹1,544₹252.05
52-Week Low₹956₹110.61
Distance from 52W High-15.76%-52.23%

Valuation

MetricMEDANTASHALBY
Market Cap₹34,818 Cr₹1,325 Cr
P/E Ratio62.54x33.71x
P/B Ratio8.78x1.32x
EPS₹5.9₹1
Book Value₹148.18₹93.11
Dividend Yield0.04%0%

Growth

MetricMEDANTASHALBY
Revenue Growth (TTM YoY)24.5%8.5%
EPS Growth (TTM YoY)42%0%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricMEDANTASHALBY
ROE13.91%9.05%
ROCE11.9%9.51%
Net Margin12.62%3.28%
Operating Margin18.01%14.3%
Debt to Equity0.3x0.1x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricMEDANTASHALBY
Promoter Holding33%74.33%
FII Holding9.91%▲ 0.45 pp4.65%▲ 0.19 pp
DII Holding17.01%▲ 0.12 pp0.31%▲ 0.01 pp
Public Holding39.97%▼ 0.59 pp20.08%▼ 0.18 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: GLOBAL HEALTH and SHALBY.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.